Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial

Published:2018-06 Issue:6 Volume:18 Page:657-665
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Zaman Khalequ,Estívariz Concepción F,Morales Michelle,Yunus Mohammad,Snider Cynthia J,Gary Howard E,Weldon William C,Oberste M Steven,Wassilak Steven G,Pallansch Mark A,Anand Abhijeet

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference29 articles.

1. Global eradication of poliovirus: history and rationale;Dowdle,2002

2. Poliovirus vaccine—live;Sutter,2013

3. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication;Caceres;Clin Infect Dis,2001

4. National immunization days: state of the art;Birmingham;J Infect Dis,1997

5. The final phase of polio eradication: new vaccines and complex choices;Cochi;J Infect Dis,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic;The Lancet Infectious Diseases;2023-12

2. Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial;Vaccine;2023-09

3. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial;The Lancet Infectious Diseases;2023-09

4. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks;Vaccine;2023-04

5. Poliovirus Vaccine–Live;Plotkin's Vaccines;2023